SNTI logo

Senti Biosciences (SNTI) Cash From Financing

Annual CFF

$779.00 K
-$117.77 M-99.34%

December 31, 2023


Summary


Performance

SNTI Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSNTIcash flowmetrics:

Quarterly CFF

$2.44 M
+$2.44 M+100.00%

September 30, 2024


Summary


Performance

SNTI Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSNTIcash flowmetrics:

TTM CFF

$3.00 M
+$2.46 M+462.10%

September 30, 2024


Summary


Performance

SNTI TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSNTIcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

SNTI Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-99.3%+10000.0%+172.6%
3 y3 years-98.0%--
5 y5 years-98.0%--

SNTI Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.3%at low-97.9%+603.1%-97.5%+758.5%
5 y5-year-99.3%at low-97.9%+603.1%-97.5%+758.5%
alltimeall time-99.3%at low-97.9%+603.1%-97.5%+758.5%

Senti Biosciences Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.44 M(>+9900.0%)
$3.00 M(+462.1%)
Jun 2024
-
$0.00(0.0%)
$533.00 K(-34.5%)
Mar 2024
-
$0.00(-100.0%)
$814.00 K(+4.5%)
Dec 2023
$779.00 K
$556.00 K(-2517.4%)
$779.00 K(-29.1%)
Sep 2023
-
-$23.00 K(-108.2%)
$1.10 M(+72.5%)
Jun 2023
-
$281.00 K(-902.9%)
$637.00 K(-99.5%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$35.00 K(-104.0%)
$118.97 M(+0.4%)
Dec 2022
$118.55 M(+73.2%)
$876.00 K(-280.6%)
$118.55 M(+0.7%)
Sep 2022
-
-$485.00 K(-100.4%)
$117.67 M(-0.4%)
Jun 2022
-
$118.61 M(<-9900.0%)
$118.16 M(<-9900.0%)
Mar 2022
-
-$455.00 K
-$455.00 K
Dec 2021
$68.44 M(+79.9%)
-
-
Dec 2020
$38.05 M
-
-

FAQ

  • What is Senti Biosciences annual cash flow from financing activities?
  • What is the all time high annual CFF for Senti Biosciences?
  • What is Senti Biosciences annual CFF year-on-year change?
  • What is Senti Biosciences quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Senti Biosciences?
  • What is Senti Biosciences quarterly CFF year-on-year change?
  • What is Senti Biosciences TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Senti Biosciences?
  • What is Senti Biosciences TTM CFF year-on-year change?

What is Senti Biosciences annual cash flow from financing activities?

The current annual CFF of SNTI is $779.00 K

What is the all time high annual CFF for Senti Biosciences?

Senti Biosciences all-time high annual cash flow from financing activities is $118.55 M

What is Senti Biosciences annual CFF year-on-year change?

Over the past year, SNTI annual cash flow from financing activities has changed by -$117.77 M (-99.34%)

What is Senti Biosciences quarterly cash flow from financing activities?

The current quarterly CFF of SNTI is $2.44 M

What is the all time high quarterly CFF for Senti Biosciences?

Senti Biosciences all-time high quarterly cash flow from financing activities is $118.61 M

What is Senti Biosciences quarterly CFF year-on-year change?

Over the past year, SNTI quarterly cash flow from financing activities has changed by +$2.46 M (+10708.70%)

What is Senti Biosciences TTM cash flow from financing activities?

The current TTM CFF of SNTI is $3.00 M

What is the all time high TTM CFF for Senti Biosciences?

Senti Biosciences all-time high TTM cash flow from financing activities is $118.97 M

What is Senti Biosciences TTM CFF year-on-year change?

Over the past year, SNTI TTM cash flow from financing activities has changed by +$1.90 M (+172.61%)